Head-to-head · Cost-Efficiency Index
Luma Health Co vs REMEVi
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Luma Health Co
Shoppers willing to book a consult to see pricing, PENDING direct re-verification.
Visit Luma Health CoREMEVi
Cost-first shoppers who want bilingual, LegitScript-certified compounded GLP-1.
Visit REMEViThe verdict
Luma Health Co takes it, leading the Cost-Efficiency Index 81 to 80. Luma Health Co is a small telehealth weight-loss practice whose own pricing is gated behind a booking widget rather than published on a static page. REMEVi still earns a B− — Cost-first shoppers who want bilingual, LegitScript-certified compounded GLP-1.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Luma Health Co.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Luma Health Co | REMEVi |
|---|---|---|
| Cost-Efficiency Index | 81/100 | 80/100 |
| Semaglutide / mo | $90/mo (all doses, compounded) | $219/mo |
| Tirzepatide / mo | $165/mo (all doses, compounded) | $319/mo |
| Semaglutide / yr (modeled) | $1,080 | $2,628 |
| Tirzepatide / yr (modeled) | $1,980 | $3,828 |
| Coverage | 30 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #31 | #33 |
Luma Health Co
81/100Where the value is
- If the third-party figures hold up, among the lowest flat-rate prices in this batch
- Cancel-anytime claimed with no penalty
The tradeoffs
- Pricing could NOT be independently confirmed on lumahealthco.com today — it's sourced from one third-party review, and other web sources for 'Luma Health' pricing are wildly inconsistent and possibly not even about this company
- Pricing is gated behind a scheduling widget rather than a public page, which is itself a transparency gap
REMEVi
80/100Where the value is
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
The tradeoffs
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.